Who owns WHOOP? Ownership structure explained (2026)

WHOOP sells a screenless fitness and health wearable that tracks strain, recovery, sleep, and other physiological signals. The band itself is not the product people pay for over time. Access to the data and the app comes through a paid membership, which is the core of how the company makes money and a big reason investors have backed it so heavily.

That subscription model, rather than a one-time device sale, is what separates WHOOP from most of the wearable market. It also shapes the ownership question. WHOOP is not a public company, and it is not owned by a larger parent like Google or Apple. It is an independent, venture-backed business whose control sits with its founders, its board, and a widening circle of institutional and celebrity investors.

This article traces who actually owns WHOOP: how the equity is split between founders and outside backers, which investors led each round, and why a private ownership structure gives the company room to run while it weighs an eventual public listing.

WHOOP, formally WHOOP, Inc., was founded in 2012 by Will Ahmed, John Capodilupo, and Aurelian Nicolae. Ahmed conceived the idea as a Harvard undergraduate and squash team captain who wanted to understand the strain and recovery that training put on the body. He built early prototypes at the Harvard Innovation Lab with Capodilupo, who studied computer science and statistics, and Nicolae, who handled the hardware engineering. The company is headquartered in Boston, Massachusetts.

The product is a wrist-worn band with no screen. It streams heart rate, heart rate variability, respiratory rate, skin temperature, sleep, and activity data into the WHOOP app, which turns those signals into daily strain, recovery, and sleep scores. WHOOP gives the hardware away as part of a subscription. Members pay a recurring fee for the membership, and the band is included, a model closer to a software service than to a consumer electronics sale.

That approach has produced fast recurring revenue growth. WHOOP reported that bookings grew 103% year over year through 2025, reaching an annualized run rate of roughly $1.1 billion, and that it was cash flow positive in 2025. By early 2026 the company said it had more than 2.5 million members globally. Those figures, and the $10.1 billion valuation the market assigned in 2026, are the kind of numbers a business valuation calculator helps put in perspective against a company still reinvesting for growth.

WHOOP is a privately held company. It has no stock ticker, files no quarterly reports with the Securities and Exchange Commission, and is not a subsidiary of any larger corporation. When people ask who owns WHOOP, the answer is its founders together with the venture capital firms, sovereign wealth funds, strategic corporate investors, and individual backers who have bought equity across more than a decade of funding rounds.

This makes WHOOP different from wearable rivals tied to public parents. The Apple Watch belongs to Apple, a listed company, and Fitbit is owned by Google. WHOOP's closest independent comparison is Oura, the smart ring maker, which is also privately held and venture backed. Both companies have chosen to stay private while they scale a subscription business.

Will Ahmed, John Capodilupo, and Aurelian Nicolae founded the company and retain founder equity, but WHOOP has not disclosed the precise size of their stakes. Like most venture-backed startups that have raised close to $1 billion across many rounds, the founders' combined ownership has been diluted with each financing as new investors bought in and the company issued employee stock. Ahmed remains the largest and most visible founder-owner as CEO, though the exact percentage is not public.

What is clear is that no single outside investor holds a controlling majority. WHOOP's cap table is spread across many funds and individuals, which typically leaves founders and management with meaningful influence over strategy even when their combined economic stake is well below 50%. The company has not disclosed whether it uses a dual-class share structure, so founder voting control cannot be confirmed from public sources.

WHOOP has raised money steadily since 2013 across a seed round and Series B through G. Early-round figures are reported less consistently across data providers, so the amounts below reflect the most widely cited public reporting. Valuations were disclosed only for the later rounds.

Total funding across these rounds is roughly $980 million, close to $1 billion. The 2020 Series E made WHOOP a unicorn, the 2021 Series F tripled that valuation to $3.6 billion, and the 2026 Series G nearly tripled it again to $10.1 billion.

SoftBank Vision Fund 2 led the $200 million Series F in August 2021 and remains one of WHOOP's most significant backers. Its investment set the $3.6 billion valuation and brought Kristin Bannon of SoftBank Investment Advisers onto the WHOOP board.

IVP, a late-stage venture firm, led the $100 million Series E in 2020 that first pushed WHOOP past a $1 billion valuation, and it continued to back the company through later rounds. Foundry Group led the 2019 Series D and has been an early institutional anchor. Collaborative Fund, which had participated in earlier rounds, stepped up to lead the $575 million Series G in 2026.

Other longstanding venture backers include Two Sigma Ventures, Accomplice, NextView Ventures, Promus Ventures, and CAVU Ventures. The 2026 Series G widened the base further, adding sovereign and strategic investors including the Qatar Investment Authority, Mubadala Investment Company, and 2PointZero Group, plus healthcare names Abbott and the Mayo Clinic. WHOOP has also drawn an unusually deep bench of athlete and celebrity investors over the years, including Cristiano Ronaldo, LeBron James, Rory McIlroy, Patrick Mahomes, Kevin Durant, and Jack Dorsey, whose involvement doubles as marketing for a product built around athletic performance.

WHOOP has not filed to go public, but its 2026 fundraising was widely read as a step toward an eventual initial public offering. Reporting around the Series G framed the $575 million raise and $10.1 billion valuation as positioning for a public listing, supported by the company reaching positive cash flow and a $1.1 billion revenue run rate. No timeline or filing has been confirmed, so an IPO remains a signal rather than a scheduled event.

Will Ahmed is WHOOP's co-founder and chief executive officer, and he has led the company since founding it in 2012. He is the public face of the business and its most influential decision-maker, setting product direction and leading each fundraising round. As the lead founder he holds the largest founder stake, though WHOOP has not disclosed the figure.

John Capodilupo, a co-founder, serves as chief technology officer and leads the data science and algorithm work that turns raw sensor signals into WHOOP's strain and recovery scores. Aurelian Nicolae, the third co-founder, focused on hardware engineering in the company's early years. Around the founders sits a management team overseeing product, engineering, membership, and international expansion, with the company hiring aggressively across research and global growth roles into 2026.

WHOOP's board reflects its investor base. Kristin Bannon of SoftBank Investment Advisers joined the board after the 2021 Series F, giving the fund a formal seat alongside earlier venture directors. As a private company, WHOOP does not publish a full board roster the way a listed company must, so the complete composition is not fully disclosed. What is confirmed is that control is shared between the founders and the major investors who hold board representation, rather than concentrated in any single outside owner.

In May 2025, WHOOP launched its WHOOP 5.0 band and a higher tier called WHOOP MG, which added a Blood Pressure Insights (BPI) feature that gives members estimated systolic and diastolic ranges. On July 14, 2025, the US Food and Drug Administration issued WHOOP a warning letter, arguing the feature qualifies as a medical device because daily blood pressure estimates are inherently tied to the diagnosis of high or low blood pressure, and that WHOOP had marketed it without regulatory clearance.

WHOOP pushed back, framing BPI as a wellness rather than a diagnostic feature. The FDA countered that inaccurate readings could put users at risk if they used them to guide treatment. The dispute continued into 2026 before the FDA sent a closeout letter, stating it no longer intended to enforce the requirements because WHOOP had modified the product and its labeling in response. The episode is the kind of regulatory exposure a young company might track in a formal risk register, since it touched the company's product roadmap directly.

The warning letter became the anchor for a proposed class action against WHOOP, with plaintiffs pointing to the FDA's findings to allege the company misrepresented the blood pressure feature. Consumer litigation of this kind is a business and reputational risk rather than confirmed wrongdoing, but it illustrates how a regulatory dispute can spill into the courts and weigh on a company preparing for a possible public listing.

WHOOP has also faced customer criticism tied to its subscription model, including disputes over how existing members could access new hardware without extending or paying for their memberships. Because the band is bundled into a recurring subscription rather than sold outright, upgrade policies and membership terms are a recurring source of friction, a tension inherent to the company's business model rather than a one-off event.

Ownership shapes how much freedom WHOOP has to run its own strategy. Because it is private and not controlled by a single parent or a majority investor, the company answers to its board and its cap table rather than to public shareholders reacting to every quarter. That has let WHOOP prioritize membership growth and product development, including expensive bets like new sensors and AI health models, without the disclosure pressure a listed company faces. A private structure also let it dispute the FDA warning letter on its own terms rather than under the glare of public markets.

The breadth of WHOOP's investor base is its own kind of protection. With money from venture firms, sovereign wealth funds, strategic healthcare players, and dozens of athletes, no one holder can force a sale or dictate direction. That dispersion keeps founders influential and gives management a long runway. It also means the company must eventually deliver a return to a large and varied group of backers, which is part of why the 2026 Series G was read as a step toward an IPO. Investors who put in $575 million at a $10.1 billion valuation will want a path to liquidity.

For the founders, the structure has preserved control while raising close to $1 billion. Will Ahmed still leads the company he started in a Harvard lab, and co-founder John Capodilupo still runs its technology. That continuity is rarer than it looks after this many rounds, and it reflects a cap table where no outside investor holds a controlling block. The trade-off is that each round dilutes the founders further, and a future public listing would spread ownership wider still.

For members, private ownership mostly stays in the background, but it matters at the edges. WHOOP's need to keep growing bookings to justify its valuation feeds directly into pricing, membership terms, and how fast it ships new features. The same growth ambition that attracted a $10.1 billion valuation also shapes decisions like the blood pressure feature that drew regulatory scrutiny. Understanding who owns WHOOP, and what those owners expect, helps explain why the company behaves the way it does. Mapping that competitive and strategic position is what a market analysis template is built for.

WHOOP is a private company owned by its founders and a large group of investors. The founders, led by CEO Will Ahmed, hold founder equity, while venture firms such as SoftBank Vision Fund 2, IVP, Foundry Group, and Collaborative Fund, along with sovereign funds, strategic backers, and athlete investors, own the rest. No single owner holds a controlling majority, and there is no parent company.

No. WHOOP is privately held and does not trade on any stock exchange. Its 2026 Series G raise at a $10.1 billion valuation was widely seen as a step toward a possible initial public offering, but the company has not filed to go public or confirmed a timeline.

WHOOP was founded in 2012 by Will Ahmed, John Capodilupo, and Aurelian Nicolae, who developed the first prototypes at the Harvard Innovation Lab. Ahmed is the co-founder and CEO, and Capodilupo is the chief technology officer.

WHOOP does not disclose exact stakes. Its most significant institutional investors include SoftBank Vision Fund 2, which led the 2021 Series F, IVP, Foundry Group, and Collaborative Fund, which led the 2026 Series G. Founder Will Ahmed holds the largest individual founder stake. The 2026 round also brought in the Qatar Investment Authority, Mubadala, Abbott, and the Mayo Clinic.

WHOOP has raised roughly $980 million across its funding rounds since 2013. Its valuation reached $1.2 billion in the 2020 Series E, $3.6 billion in the 2021 Series F led by SoftBank, and $10.1 billion in the 2026 Series G led by Collaborative Fund, nearly tripling in each of the last two rounds.

Will Ahmed is the co-founder and CEO of WHOOP and has led the company since he started it in 2012. He is the company's largest founder-owner and its most influential decision-maker, setting product strategy and leading each fundraising round.